Distributions of current and new first-trimester Down syndrome screening markers in twin pregnancies

Prenatal Diagnosis

Volumn 30, Issue 5, 2010, Pages 413-417

  Koster, M P H ^a,b   Wortelboer, E J ^b   Stoutenbeek, Ph ^b   Visser, G H A ^b   Schielen, P C J I ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

ADAM12; First trimester; Free beta hCG; PAPP A; PP13; Twins

Indexed keywords

ADAM PROTEIN; ADAM12 PROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; PLACENTA PROTEIN; PLACENTA PROTEIN 13; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG;

ARTICLE; BETA CHAIN; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DOWN SYNDROME; FIRST TRIMESTER PREGNANCY; HUMAN; PARAMETER; PREGNANCY; PRIORITY JOURNAL; SCREENING; TWIN PREGNANCY;

ADAM PROTEINS; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DISEASES IN TWINS; DOWN SYNDROME; FEMALE; GALECTINS; GESTATIONAL AGE; HUMANS; MEMBRANE PROTEINS; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS;

EID: 77951735531     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2483     Document Type: Article

References (32)

1. Amor DJ, Xu JX, Halliday JL, et al. 2009. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome. Hum Reprod 24(6): 1330-1338.
2. Brambati B, Macintosh MC, Teisner B, et al. 1993. Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype. Br J Obstet Gynaecol 100(4): 324-326. (Pubitemid 23121151)
3. Cuckle H. 1998. Down's syndrome screening in twins. J Med Screen 5(1): 3-4.
4. Cuckle H, Benn P, Wright D. 2005. Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters. Semin Perinatol 29(4): 252-257. (Pubitemid 41133566)
5. Gielen M, Lindsey PJ, Derom C, et al. 2006. Curves of placental weights of live-born twins. Twin Res Hum Genet 9(5): 664-672. (Pubitemid 44622035)
6. Goncé A, Borrell A, Fortuny A, et al. 2005. First-trimester screening for trisomy 21 in twin pregnancy: does the addition of biochemistry make an improvement? Prenat Diagn 25(12): 1156-1161. (Pubitemid 43016299)
7. Gonen R, Shahar R, Grimpel YI, et al. 2008. Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study. Br J Obstet Gynaecol 115(12): 1465-1472.
8. Koster MP, Wortelboer EJ, Cuckle HS, Stoutenbeek P, Visser GH, Schielen PC. 2009. Placental Protein 13 as a first trimester screening marker for aneuploidy. Prenat Diagn 29(13): 1237-1241.
9. Laigaard J, Sørensen T, Placing S, et al. 2005. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Obstet Gynecol 106(1): 144-149. (Pubitemid 40898447)
10. Laigaard J, Cuckle H, Wewer UM, Christiansen M. 2006. Maternal serum ADAM12 levels in Down and Edwards' syndrome pregnancies at 9-12 weeks' gestation. Prenat Diagn 26(8): 689-691. (Pubitemid 44252243)
11. Linskens IH, Spreeuwenberg MD, Blankenstein MA, van Vugt JM. 2009. Early first-trimester free beta-hCG and PAPP-A serum distributions in monochorionic and dichorionic twins. Prenat Diagn 29(1): 74-78.
12. Mashiach R, Orr-Urtreger A, Yaron Y. 2004. A comparison between maternal serum free beta-human chorionic gonadotrophin and pregnancy-associated plasma protein A levels in first-trimester twin and singleton pregnancies. Fetal Diagn Ther 19(2): 174-177. (Pubitemid 38209777)
13. Muller F, Dreux S, Dupoizat H, et al. 2003. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity. Prenat Diagn 23(4): 331-335. (Pubitemid 36457270)
14. Neveux LM, Palomaki GE, Knight GJ, Haddow JE. 1996. Multiple marker screening for Down syndrome in twin pregnancies. Prenat Diagn 16(1): 29-34. (Pubitemid 26029868)
15. Niemimaa M, Suonpää M, Heinonen S, Seppal̈ä M, Bloigu R, Ryynänen M. 2002. Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A in twin pregnancies in the first trimester. Prenat Diagn 22(3): 183-185. (Pubitemid 34245828)
16. Noble PL, Snijders RJ, Abraha HD, Sherwood RA, Nicolaides KH. 1997. Maternal serum free beta-hCG at 10 to 14 weeks of gestation in trisomic twin pregnancies. Br J Obstet Gynaecol 104(6): 741-743.
17. Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH. 2009. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol 33(1): 23-33.
18. Romero R, Kusanovic JP, Than NG, et al. 2008. First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynecol 199(2): 122.e1-122.e11.
19. Sebire NJ, Snijders RJ, Hughes K, Sepulveda W, Nicolaides KH. 1997. The hidden mortality of monochorionic twin pregnancies. Br J Obstet Gynaecol 104(10): 1203-1207. (Pubitemid 27406495)
20. Sepulveda W, Sebire NJ, Hughes K, Odibo A, Nicolaides KH. 1996. The lambda sign at 10-14 weeks of gestation as a predictor of chorionicity in twin pregnancies. Ultrasound Obstet Gynecol 7(6): 421-423. (Pubitemid 126720282)
21. Shetty A, Smith AP. The sonographic diagnosis of chorionicity. 2005. Prenat Diagn. 25(9): 735-739.
22. Sibai BM, Hauth J, Caritis S, et al. 2000. Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 182(4): 938-942.
23. Spencer K. 2000. Screening for trisomy 21 in twin pregnancies in the first trimester using free beta-hCG and PAPP-A, combined with fetal nuchal translucency thickness. Prenat Diagn 20(2): 91-95. (Pubitemid 30103459)
24. Spencer K. 2001. Screening for trisomy 21 in twin pregnancies in the first trimester: does chorionicity impact on maternal serum free beta-hCG or PAPP-A levels? Prenat Diagn 21(9): 715-717. (Pubitemid 32929121)
25. Spencer K, Nicolaides KH. 2003. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience. Br J Obstet Gynecol 110(3): 276-280. (Pubitemid 36298911)
26. Spencer K, Macri JN, Aitken DA, Connor JM. 1992. Free betahCG as first-trimester marker for fetal trisomy. Lancet 339(8807): 1480-1480
27. Spencer K, Heath V, El-Sheikhah A, Ong CY, Nicolaides KH. 2005. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations. Prenat Diagn 25(5): 365-369. (Pubitemid 40813777)
28. Spencer K, Kagan KO, Nicolaides KH. 2008a. Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers. Prenat Diagn 28(1): 49-52. (Pubitemid 351251990)
29. Spencer K, Vereecken A, Cowans NJ. 2008b. Maternal serum ADAM12s as a potential marker of trisomy 21 prior to 10 weeks of gestation. Prenat Diagn 28(3): 209-211. (Pubitemid 351427939)
30. Vayssière CF, Heim N, Camus EP, Hillion YE, Nisand IF. 1996. Determination of chorionicity in twin gestations by high-frequency abdominal ultrasonography: counting the layers of the dividing membrane. Am J Obstet Gynecol 175(6): 1529-1533. (Pubitemid 27021024)
31. Wøjdemann KR, Larsen SO, Shalmi AC, Sundberg K, Tabor A, Christiansen M. 2006. Nuchal translucency measurements are highly correlated in both mono- and dichorionic twin pairs. Prenat Diagn 26(3): 218-220.
32. Wortelboer EJ, Linskens IH, Koster MP, et al. 2009. ADAM12s as a first-trimester screening marker of trisomy. Prenat Diagn 29(9): 866-869.